S N D Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 22.84%
- Profit Growth -32.28%
- Ebitda -32.28%
- Net Worth 62.61%
- Total Assets 395.47%
About S N D Life Science
S N D Life Science Private Limited (SNDLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 August 2011 and has a history of 13 years and six months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Mehta, Sudhir Gautam, and Jyotsna Gautam serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233MH2011PTC221314
- Company No.
221314
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Aug 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at S N D Life Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Mehta  | Director | Current | |
| Sudhir Gautam | Director | 26-Aug-2011 | Current |
| Jyotsna Gautam | Director | 15-Jun-2012 | Current |
Financial Performance of S N D Life Science.
S N D Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.84% increase. The company also saw a substantial fall in profitability, with a 32.28% decrease in profit. The company's net worth Soared by an impressive increase of 62.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S N D Life Science?
In 2023, S N D Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Decx Technology Private LimitedManoj Mehta is a mutual person
Lord Lifescience Private LimitedManoj Mehta is a mutual person
- Pure Life Science Private Limited
Manoj Mehta is a mutual person
- Vfm Pharma Private Limited
Manoj Mehta is a mutual person
- Plus Trading And Management Private Limited
Manoj Mehta is a mutual person
- Basket Technologies Private Limited
Manoj Mehta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at S N D Life Science?
Unlock and access historical data on people associated with S N D Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S N D Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S N D Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
